Trial Profile
Modifying tacrolimus related toxicity after liver transplantation. A randomized controlled trial comparing Envarsus and Advagraf in de novo liver transplant recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Pharmacodynamics
- Acronyms MOTTO
- 22 Dec 2022 Status changed from not yet recruiting to completed.
- 17 Nov 2018 New trial record